SCYNEXIS, Inc. Loans Payable, Noncurrent
SCYNEXIS, Inc. (SCYX) had Loans Payable, Noncurrent of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLoansPayable · last filed 2024-03-28
- 2023-12-31: Loans Payable, Noncurrent $0.00.
- 2023-09-30: Loans Payable, Noncurrent $0.00.
- 2023-06-30: Loans Payable, Noncurrent $0.00.
- 2023-03-31: Loans Payable, Noncurrent $0.00.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $34.39M 10-K · filed 2024-03-28 |
| 2022-09-30 | $34.16M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $33.94M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $33.71M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $28.75M 10-K · filed 2023-03-31 |
| 2021-09-30 | $28.58M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $28.38M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |